Market Overview

UPDATE: Oppenheimer Raises PT to $37 on Oracle Following Positive Q2 Results

Share:
Related ORCL
Earnings Season: Your Guide To When Each Sector Reports
Analyst: Blockchain Is The Biggest Thing Since The Internet And Cryptocurrencies Are Just The First Generation Of Its Applications
The Intelligent Investor: Portfolio Policy For 2018 (Seeking Alpha)

Oppenheimer reiterated its Outperform rating on Oracle (NASDAQ: ORCL) and increased its price target from $36 to $37.

Oppenheimer said, "We believe Oracle's internally-driven new product-cycles are gaining traction within the base, and as the uptake becomes more meaningful (over the next 12-18 months) it should start yielding greater operating leverage and serve as a catalyst to drive a revaluation of the stock multiple."

Oracle closed at $32.88 on Tuesday.

Latest Ratings for ORCL

DateFirmActionFromTo
Jan 2018Morgan StanleyUpgradesEqual-WeightOverweight
Dec 2017RBC CapitalDowngradesOutperformSector Perform
Nov 2017UBSAssumesBuyNeutral

View More Analyst Ratings for ORCL
View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Price Target Pre-Market Outlook Analyst Ratings

 

Related Articles (ORCL)

View Comments and Join the Discussion!